Gufic BioSciences Ltd (GUFICBIO) — Announcement | 24 September 2026
Gufic BioSciences disclosed penalties of ₹8,000 and [amount not verified] imposed by BSE and NSE for appointing a director over 75 without shareholder approval, paid the first penalty, and now faces pending payment of the second penalty by October 3, 2026 following waiver rejections.
About Gufic BioSciences Ltd (GUFICBIO)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when GUFICBIO files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track GUFICBIO — Free💡 Ask AI about this filing
📊 More GUFICBIO filings
- 🔴 Announcement — 29 September 2026Gufic BioSciences announced it received an appellate order from the Commissioner of Income Tax (Appe...
- 🔴 Announcement — 28 September 2026Gufic BioSciences announced that Crisil ESG Ratings assigned an overall ESG rating of CRISIL ESG 62 ...
- Announcement — 28 September 2026Gufic BioSciences announced that its trading window will close on October 1, 2026, and remain shut u...
- 🔴 Announcement — 8 September 2026Gufic BioSciences announced that CRISIL reaffirmed its credit ratings on bank facilities, upgrading ...
- 🟡 Board Meeting — 4 September 2026Gufic Biosciences held its 42nd AGM on September 4, 2026 via video conference, approving the audited...
🔥 Also filed on 24 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when GUFICBIO files new disclosures
Track GUFICBIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GUFICBIO — FreeFree account · 2 AI queries/day